loading

Enliven Therapeutics Inc (ELVN) 財務データ

損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
期間の長さ 3 か月 3 か月 3 か月 3 か月 3 か月
Revenues
-
- - - -
Operating Expenses
17.84%
31.69
26.90 27.07 24.60 25.99
Operating Income/Loss
17.84%
-31.69
-26.90 -27.07 -24.60 -25.99
Nonoperating Income/Loss
15.26%
3.149
3.716 3.912 4.653 3.249
Income/Loss From Continuing Operations Before Tax
23.14%
-28.54
-23.18 -23.16 -19.95 -22.74
Income/Loss From Continuing Operations After Tax
23.14%
-28.54
-23.18 -23.16 -19.95 -22.74
Net Income/Loss
23.14%
-28.54
-23.18 -23.16 -19.95 -22.74
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,251%
50.05
0.9354 48.27 48.08 42.05
Diluted Average Shares
5,251%
50.05
0.9354 48.27 48.08 42.05
Basic Earnings Per Share
23.91%
-0.57
-0.46 -0.48 -0.41 -0.54
Diluted Earnings Per Share
23.91%
-0.57
-0.46 -0.48 -0.41 -0.54
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.82
price up icon 1.29%
$85.11
price up icon 0.57%
$26.18
price down icon 0.50%
$109.86
price down icon 0.90%
$132.26
price up icon 0.49%
biotechnology ONC
$318.01
price up icon 1.18%
大文字化:     |  ボリューム (24 時間):